Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 19051 - 19075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	PNMA2	10687	upregulated	[Disulfiram binds to Copper] which results in increased expression of PNMA2 mRNA	8p21.2	A21750
Copper	Approved Investigational	PNPLA4	8228	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PNPLA4 mRNA	Xp22.31	A21749
Copper	Approved Investigational	PNPLA8	50640	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PNPLA8 mRNA	7q31.1	A21749
Copper	Approved Investigational	PNPO	55163	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PNPO mRNA	17q21.32	A21749
Copper	Approved Investigational	POLA1	5422	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of POLA1 mRNA	Xp22.11-p21.3	A21749
Copper	Approved Investigational	POLA2	23649	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of POLA2 mRNA	11q13.1	A21749
Copper	Approved Investigational	POLD1	5424	upregulated	Copper results in increased expression of POLD1 mRNA	19q13.3	A21759
Copper	Approved Investigational	POLD1	5424	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of POLD1 mRNA	19q13.3	A21749
Copper	Approved Investigational	POLD3	10714	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of POLD3 mRNA	11q13.4	A21749
Copper	Approved Investigational	POLE2	5427	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of POLE2 mRNA	14q21.3	A21749
Copper	Approved Investigational	POLR2C	5432	downregulated	[Disulfiram binds to Copper] which results in decreased expression of POLR2C mRNA	16q21	A21750
Copper	Approved Investigational	POLR2M	81488	downregulated	[Disulfiram binds to Copper] which results in decreased expression of POLR2M mRNA	15q21.3	A21750
Copper	Approved Investigational	POLR3K	51728	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of POLR3K mRNA	16p13.3	A21749
Copper	Approved Investigational	POP1	10940	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of POP1 mRNA	8q22.2	A21749
Copper	Approved Investigational	POP4	10775	downregulated	[Disulfiram binds to Copper] which results in decreased expression of POP4 mRNA	19q12	A21750
Copper	Approved Investigational	POP7	10248	downregulated	Copper results in decreased expression of POP7 mRNA	7q22.1	A21752
Copper	Approved Investigational	POR	5447	upregulated	[NSC 689534 binds to Copper] which results in increased expression of POR mRNA	7q11.23	A21749
Copper	Approved Investigational	POSTN	10631	upregulated	[Disulfiram binds to Copper] which results in increased expression of POSTN mRNA	13q13.3	A21750
Copper	Approved Investigational	POU3F2	5454	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of POU3F2 mRNA	6q16.1	A21749
Copper	Approved Investigational	PPAN	56342	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PPAN mRNA	19p13.2	A21749
Copper	Approved Investigational	PPARGC1B	133522	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PPARGC1B mRNA	5q32	A21749
Copper	Approved Investigational	PPIA	5478	downregulated	[Disulfiram binds to Copper] which results in decreased expression of PPIA mRNA	7p13	A21750
Copper	Approved Investigational	PPIA	5478	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PPIA mRNA	7p13	A21749
Copper	Approved Investigational	PPM1H	57460	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PPM1H mRNA	12q14.1-q14.2	A21749
Copper	Approved Investigational	PPP1R15A	23645	downregulated	[Disulfiram binds to Copper] which results in decreased expression of PPP1R15A mRNA	19q13.2	A21750

Displaying entries 19051 - 19075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability